466 related articles for article (PubMed ID: 34877514)
1. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.
Wei R; Yang J; Cheng CW; Ho WI; Li N; Hu Y; Hong X; Fu J; Yang B; Liu Y; Jiang L; Lai WH; Au KW; Tsang WL; Tse YL; Ng KM; Esteban MA; Tse HF
JHEP Rep; 2022 Jan; 4(1):100389. PubMed ID: 34877514
[TBL] [Abstract][Full Text] [Related]
2. Retinoids rescue ceruloplasmin secretion and alleviate oxidative stress in Wilson's disease-specific hepatocytes.
Song D; Takahashi G; Zheng YW; Matsuo-Takasaki M; Li J; Takami M; An Y; Hemmi Y; Miharada N; Fujioka T; Noguchi M; Nakajima T; Saito MK; Nakamura Y; Oda T; Miyaoka Y; Hayashi Y
Hum Mol Genet; 2022 Oct; 31(21):3652-3671. PubMed ID: 35388883
[TBL] [Abstract][Full Text] [Related]
3. Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin.
Zhang S; Chen S; Li W; Guo X; Zhao P; Xu J; Chen Y; Pan Q; Liu X; Zychlinski D; Lu H; Tortorella MD; Schambach A; Wang Y; Pei D; Esteban MA
Hum Mol Genet; 2011 Aug; 20(16):3176-87. PubMed ID: 21593220
[TBL] [Abstract][Full Text] [Related]
4. Human Embryonic Stem Cell-Derived Wilson's Disease Model for Screening Drug Efficacy.
Kim D; Kim SB; Ryu JL; Hong H; Chang JH; Yoo TJ; Jin X; Park HJ; Han C; Lee BH; Choi JH; Yoo HW; Kim JH; Woo DH
Cells; 2020 Apr; 9(4):. PubMed ID: 32252475
[TBL] [Abstract][Full Text] [Related]
5. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.
Cai H; Cheng X; Wang XP
Hepatology; 2022 Oct; 76(4):1046-1057. PubMed ID: 35340061
[TBL] [Abstract][Full Text] [Related]
6. Generation of ZJUi003-A, an induced pluripotent stem cell line from a Wilson's disease patient carrying a c.180_181del mutation in ATP7B gene.
Wang J; Su J; Gong T; Li T; Shen J; Wang H; Xie H; Zhou L; Zheng S; Liang P
Stem Cell Res; 2020 Jul; 46():101873. PubMed ID: 32534167
[TBL] [Abstract][Full Text] [Related]
7. [Genotype and phenotype correlation in Chinese patients with Wilson's Disease].
Liu XQ; Zhang YF; Liu TT; Gu XF; Hsiao KJ; Bao KR; Yu LH
Zhonghua Er Ke Za Zhi; 2003 Jan; 41(1):35-8. PubMed ID: 14761325
[TBL] [Abstract][Full Text] [Related]
8. ATP7B R778L mutant hepatocytes resist copper toxicity by activating autophagy and inhibiting necroptosis.
Tang S; Liang C; Hou W; Hu Z; Chen X; Zhao J; Zhang W; Duan Z; Bai L; Zheng S
Cell Death Discov; 2023 Sep; 9(1):344. PubMed ID: 37717021
[TBL] [Abstract][Full Text] [Related]
9. Liposome-encapsulated curcumin attenuates HMGB1-mediated hepatic inflammation and fibrosis in a murine model of Wilson's disease.
Ho WI; Hu Y; Cheng CW; Wei R; Yang J; Li N; Au KW; Tse YL; Wang Q; Ng KM; Esteban MA; Tse HF
Biomed Pharmacother; 2022 Aug; 152():113197. PubMed ID: 35687913
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Correction of Copper Metabolism in Wilson's Disease Mice with AAV8 Vector Delivering Truncated ATP7B.
Leng Y; Li P; Zhou L; Xiao L; Liu Y; Zheng Z; Qin F; Hao Q; Xu H; Yao S; Dong B
Hum Gene Ther; 2019 Dec; 30(12):1494-1504. PubMed ID: 31668086
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic characterization of a large cohort of patients with Wilson's disease in China.
Zhang S; Yang W; Li X; Pei P; Dong T; Yang Y; Zhang J
Transl Neurodegener; 2022 Feb; 11(1):13. PubMed ID: 35220961
[TBL] [Abstract][Full Text] [Related]
12. Establishment of hepatic and neural differentiation platforms of Wilson's disease specific induced pluripotent stem cells.
Yi F; Qu J; Li M; Suzuki K; Kim NY; Liu GH; Belmonte JC
Protein Cell; 2012 Nov; 3(11):855-63. PubMed ID: 22806248
[TBL] [Abstract][Full Text] [Related]
13. Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.
Huster D; Hoppert M; Lutsenko S; Zinke J; Lehmann C; Mössner J; Berr F; Caca K
Gastroenterology; 2003 Feb; 124(2):335-45. PubMed ID: 12557139
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B.
Pöhler M; Guttmann S; Nadzemova O; Lenders M; Brand E; Zibert A; Schmidt HH; Sandfort V
PLoS One; 2020; 15(9):e0239411. PubMed ID: 32997714
[TBL] [Abstract][Full Text] [Related]
15. Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models.
Mi X; Li Z; Yan J; Li Y; Zheng J; Zhuang Z; Yang W; Gong L; Shi J
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165842. PubMed ID: 32446740
[TBL] [Abstract][Full Text] [Related]
16. In
Sharma Y; Liu J; Kristian KE; Follenzi A; Gupta S
Gene Expr; 2018 Dec; 19(1):15-24. PubMed ID: 30029699
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
18. Defective roles of ATP7B missense mutations in cellular copper tolerance and copper excretion.
Zhu M; Dong Y; Ni W; Wu ZY
Mol Cell Neurosci; 2015 Jul; 67():31-6. PubMed ID: 26032686
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of hepatocyte-like-cells converted from stem cells from human exfoliated deciduous teeth in fulminant Wilson's disease.
Fujiyoshi J; Yamaza H; Sonoda S; Yuniartha R; Ihara K; Nonaka K; Taguchi T; Ohga S; Yamaza T
Sci Rep; 2019 Feb; 9(1):1535. PubMed ID: 30733544
[TBL] [Abstract][Full Text] [Related]
20. [Phenotype and genotype analysis of 55 children patients with Wilson's disease].
Zhou XY; Yin HX; Wang CL; Liu ZF; Zheng BX; Jin Y
Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):603-607. PubMed ID: 32791797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
